Treatment of Soft Tissue Injury in Athletes by Biological Method
DOI:
https://doi.org/10.52340/spectri.2023.08.02.11Keywords:
of platelet-rich plasma, meniscus, ligamentsAbstract
Recently, in the treatment of soft tissue trauma, autologous preparations made of blood plasma with a high platelet content (PRP) are used, it is obtained from the patient's own blood and contains various growth factors and other biomolecules necessary for the healing of the injury. Platelets, the main component of PRGF, contain 1500 different bioactive factors, these factors include - messengers of the immune system, enzymes and their inhibitors, and other factors that can participate in tissue repair.
Current research surrounding PRP therapy has significant limitations in terms of article bias, lack of preparation standardization, and insufficient multicenter randomized large clinical trials, although PRP has shown potential benefits for certain clinical indications, specifically wound, tendon, and ligament healing. Because PRP is biologically unique to different people, it is difficult to determine the true effectiveness of the therapy. More attention should be paid to standardizing methods of preparation and administration of PRP to determine true efficacy.
Conclusion: The use of platelet-rich plasma in the treatment of soft tissue injuries during sports injuries is a promising method.
Downloads
References
De Maeseneer M, Van RoyP., Shahabpour M, Gosselin R, Normal Anatomy and Pathology of the Posterior Capsular Area of the Knee: Findings in Cadaveric Specimens and in Patients. American Journal of Roentgenology 2004 182:4, 955-962
Bruce Hamilton, Medical management of hamstring muscle injury: strained evidence for platelet rich plasma.Br J Sports Med, 2014
Smith C, Kruger MJ, Smith RM, et al. The infl ammatory response to skeletal muscle injury: illuminating complexities. Sports Med 2008;38:947–69.
Anitua E, Sanchez M, Orive G, et al. A biological therapy to osteoarthritis treatment using platelet-rich plasma. Expert Opinion on Biological Therapy. 2013;13(8):1–12.
Engebretsen, L., Steffen, K., Alsousou, J., Anitua, E., Bachl, N., Devilee, R., Everts, P., Hamilton, B., Huard, J., Jenoure, P., Kelberine, F., Kon, E., Maffulli, N., Matheson, G., Mei-Dan, O., Menetrey, J., Philippon, M., Randelli, P., Schamasch, P., Schwellnus, M., Vernec, A. and Verrall, G. () IOC consensus paper on the use of platelet-rich plasma in sports medicine. British journal of Sports Medicine. 2010, 44, 1072-1081
Mei-Dan O, Mann G, Maffulli NPlatelet-rich plasma: any substance into it?British Journal of Sports Medicine 2010;44:618-619.
Boswell S.G., Cole B.J., Sundman E.A., Karas V., Fortier L.A., Platelet-rich plasma: a milieu of bioactive factors, Arthroscopy, 2012, 28, 429-439.
Marques L.F., Stessuk T., Camargo I.C., Sabeh Junior N., dos Santos L., Ribeiro-Paes J.T., Platelet-rich plasma (PRP): methodological aspects and clinical applications, Platelets, 2015, 26, 101-113
Andia I, Maffulli N.Platelet-rich Plasma for Muscle Injury and Tendinopathy. Sports Medicine and Arthroscopy Review. 2013 DEC. 21(4):191–198.
Tchetina, E. V. “Developmental mechanisms in articular cartilage degradation in osteoarthritis,”Arthritis, vol. 2011, Article ID 683970, 2011. 16 pages.
Cheng M., Johnson V. M., and Murray M. M., “Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression,” Journal of Orthopaedic Research, , 2012.vol. 30, no. 1, pp. 79–85.
van Buul GM, Koevoet WLM, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. The American Journal of Sports Medicine. 2011;39(11):2362–2370.
Leong DJ, Li YH, Gu XI, et al. Physiological loading of joints prevents cartilage degradation through CITED2. The FASEB Journal. 2011;25(1):182–191.
Ishida K, Kuroda R, Miwa M, et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Engineering. 2007;13(5):1103–1112.
Wei L-C, Gao S-G, Xu M, Jiang W, Tian J, Lei G-H. A novel hypothesis: the application of platelet-rich plasma can promote the clinical healing of white-white meniscal tears. Medical Science Monitor. 2012;18(8):47–50.
Reurink G, Goudswaard GJ, Moen MH, et alRationale, secondary outcome scores and 1-year follow-up of a randomised trial of platelet-rich plasma injections in acute hamstring muscle injury: the Dutch Hamstring Injection Therapy study. Br J Sports Med.Published Online First: 04 May 2015
Pavlovic, V., Ciric, M., Jovanovic, V., et al. (2016). Platelet Rich Plasma: a short overview of certain bioactive components. Open Medicine, 11(1), pp. 242-247.
Harmon K. G., Muscle injuries and PRP: what does the science say?Br J Sports Med, 2010.
Andia I, Rubio-Azpeitia E, Maffulli N. Potential links between tendon pathology and platelet rich plasma biology. Platelet Rich Plasma in Musculoskeletal Practice. 2016:223-40.
Cook J, Young M. Biologic therapies for tendon and muscle injury. UptoDate. Jun. 2020.
Dos Santos RG, Santos GS, Alkass N, Chiesa TL, Azzini GO, da Fonseca LF, Dos Santos AF, Rodrigues BL, Mosaner T, Lana JF. The regenerative mechanisms of platelet-rich plasma: A review. Cytokine. 2021 Aug 1;144:155560
Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med. 2013 Sep;8(5):645-58.
Anitua E, PradoR, Troya M, Zalduendo M, Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration.Platelets Vol. 27, Iss. 5, 2016
Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert review of hematology. 2021 Jan 2;14(1):97-108.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
